SKOV3mirvetuximab soravtansinegemcitabineexatecanFDAplatinum-resistant ovarian cancerrecurrent diseaseepithelial ovarian cancersClone 65Sanyou Biopharmaceuticals Laboratory Animal Ethics Committee
…payload ADCs in the platinum-resistant ovarian cancer cell line SKOV3. MC003 exhibited greater potency than the individual ADCs, incl…